Paul Tudor Jones’s Verona Pharma VRNA Stock Holding History

Paul Tudor Jones’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-27,200	Closed	-$2.9M	–	4098
2025 Q3	$2.9M	Sell	27,200 -3,900	-13%	-$407K	0.01%	1557
2025 Q2	$2.94M	Buy	31,100 +13,200	+74%	+$977K	0.01%	1406
2025 Q1	$1.14M	Buy	17,900 +10,700	+149%	+$640K	﹤0.01%	1736
2024 Q4	$334K	Buy	+7,200	New	+$270K	﹤0.01%	2516

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Paul Tudor Jones's VRNA Position: Q4 2025 in Review

Paul Tudor Jones sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 400,000 shares — an estimated $42.7M sold.

Paul Tudor Jones first reported a position in VRNA in Q1 2025 and held it in 2 quarters. The position peaked at $42.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Paul Tudor Jones reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Paul Tudor Jones sold 400,000 Verona Pharma shares in Q4 2025, an estimated $42.7M.
Paul Tudor Jones first reported a position in Verona Pharma in Q1 2025 and held it in 2 quarters.
Paul Tudor Jones's Verona Pharma position peaked at $42.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.